Size doesn’t matter.

At least not as a surrogate endpoint for overall survival. This pooled analysis of 20 clinical trials shows neither size of, nor time to, tumor response correlates well with subsequent survival outcomes, with the waters especially muddied by antiangiogenic agents. | Burzykowski, JAMA Netw Open 2019